Huapont Life Sciences Co.,Ltd. (SHE: 002004)

Huapont Life Sciences Co.,Ltd. Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021	Dec 31, 2019
Operating Revenue	11,465	11,409	13,021	12,290	10,732	9,914
Other Revenue	186.02	186.02	211.45	141.06	143.9	177.3
Revenue	11,651	11,595	13,232	12,431	10,876	10,091
Revenue Growth (YoY)	-2.13%	-12.38%	6.45%	14.29%	7.78%	-4.56%
Cost of Revenue	7,564	7,208	7,971	7,759	6,469	5,451
Gross Profit	4,088	4,387	5,261	4,672	4,407	4,640
Selling, General & Admin	2,423	2,550	2,904	2,753	2,579	2,766
Research & Development	395.02	419.14	385.24	329.47	324.35	288.03
Other Operating Expenses	98.99	103.47	89.41	80.78	61.02	71.25
Operating Expenses	2,939	3,080	3,386	3,188	2,929	3,127
Operating Income	1,149	1,307	1,875	1,484	1,478	1,513
Interest Expense	-357.64	-343.7	-434.01	-461.68	-561.07	-565.45
Interest & Investment Income	35.16	92.75	529.44	380.87	323	269.35
Currency Exchange Gain (Loss)	46.5	46.5	153.25	-31.74	-76.11	14.7
Other Non Operating Income (Expenses)	-47.89	-13.62	-42.16	-55.59	-87.77	-93.63
EBT Excluding Unusual Items	824.7	1,089	2,082	1,316	1,076	1,138
Impairment of Goodwill	-208.16	-208.16	-491.85	-29.36	-	-66.14
Gain (Loss) on Sale of Investments	-50.74	1.2	-4.84	8.52	10.26	14.54
Gain (Loss) on Sale of Assets	19.72	19.51	-21.26	-22.43	2.2	13.86
Asset Writedown	-97.54	-80.36	-31.51	-93.3	-24.15	-8
Other Unusual Items	71.63	71.63	90.16	101.87	100.44	57.46
Pretax Income	559.61	892.39	1,623	1,281	1,165	1,149
Income Tax Expense	172.7	215.46	495.49	361.04	270.08	217.44
Earnings From Continuing Operations	386.91	676.93	1,127	920.2	895.01	931.9
Minority Interest in Earnings	-137.73	-374.81	-693.72	-252.4	-243.27	-311.7
Net Income	249.17	302.12	433.48	667.81	651.73	620.21
Net Income to Common	249.17	302.12	433.48	667.81	651.73	620.21
Net Income Growth	12.55%	-30.30%	-35.09%	2.47%	5.08%	22.46%
Shares Outstanding (Basic)	1,976	1,980	1,980	1,980	1,975	2,001
Shares Outstanding (Diluted)	1,976	1,980	1,980	1,980	1,975	2,001
Shares Change (YoY)	-0.20%	-0.02%	0.02%	0.25%	-1.29%	-1.24%
EPS (Basic)	0.13	0.15	0.22	0.34	0.33	0.31
EPS (Diluted)	0.13	0.15	0.22	0.34	0.33	0.31
EPS Growth	12.77%	-30.29%	-35.10%	2.21%	6.45%	24.00%
Free Cash Flow	393.2	305.35	1,277	13.19	1,142	648.66
Free Cash Flow Per Share	0.20	0.15	0.64	0.01	0.58	0.32
Dividend Per Share	0.220	0.220	0.220	0.220	0.220	0.220
Gross Margin	35.08%	37.83%	39.76%	37.58%	40.52%	45.98%
Operating Margin	9.86%	11.27%	14.17%	11.94%	13.59%	14.99%
Profit Margin	2.14%	2.61%	3.28%	5.37%	5.99%	6.15%
Free Cash Flow Margin	3.37%	2.63%	9.65%	0.11%	10.50%	6.43%
EBITDA	2,060	2,158	2,647	2,200	2,175	2,120
EBITDA Margin	17.68%	18.61%	20.00%	17.70%	19.99%	21.01%
D&A For EBITDA	911.47	851.34	771.15	716.37	696.31	607.14
EBIT	1,149	1,307	1,875	1,484	1,478	1,513
EBIT Margin	9.86%	11.27%	14.17%	11.94%	13.59%	14.99%
Effective Tax Rate	30.86%	24.14%	30.53%	28.18%	23.18%	18.92%
Revenue as Reported	11,651	11,595	13,232	12,431	-	10,091
Advertising Expenses	-	610.81	758.7	887.58	979.61	649.25

Source: S&P Capital IQ. Standard template. Financial Sources.